{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:52:33Z","timestamp":1781106753821,"version":"3.54.1"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-03033-4","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T07:12:19Z","timestamp":1757920339000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Bioactive compounds from marine algae in pancreatic cancer therapy: mechanistic insights into fucoidan and phlorotannins: a review"],"prefix":"10.1007","volume":"42","author":[{"given":"N.","family":"Prabhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Rajinikanth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathiyazhagan","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"3033_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12029-025-01183-2","volume":"56","author":"PD Leiphrakpam","year":"2025","unstructured":"Leiphrakpam PD, Chowdhury S, Zhang M, Bajaj V, Dhir M, Are C. Trends in the global incidence of pancreatic cancer and a brief review of its histologic and molecular subtypes. J Gastrointest Cancer. 2025;56:71.","journal-title":"J Gastrointest Cancer"},{"key":"3033_CR2","doi-asserted-by":"publisher","first-page":"1555963","DOI":"10.3389\/fonc.2025.1555963","volume":"15","author":"R Juthani","year":"2025","unstructured":"Juthani R, Manne A. Blood-based biomarkers in pancreatic ductal adenocarcinoma: developments over the last decade and what holds for the future\u2014a review. Front Oncol. 2025;15:1555963.","journal-title":"Front Oncol"},{"key":"3033_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41392-024-01856-7","volume":"9","author":"B Liu","year":"2024","unstructured":"Liu B, Zhou H, Tan L, Siu KTH, Guan X-Y. Exploring treatment options in cancer: tumor treatment strategies. Signal Transduct Target Ther. 2024;9:175.","journal-title":"Signal Transduct Target Ther"},{"key":"3033_CR4","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s12672-025-02773-z","volume":"16","author":"S Sadrinasab","year":"2025","unstructured":"Sadrinasab S, Saket S, Pourmohammadi N, Khosravi F, Fakhr MS. Modern therapeutic approaches for hepatic tumors: progress, limitations, and future directions. Discover Oncol. 2025;16:959.","journal-title":"Discover Oncol"},{"key":"3033_CR5","doi-asserted-by":"crossref","unstructured":"Principe DR, Underwood PW, Korc M, Trevino JG, Munshi HG, Rana A. The current treatment paradigm for pancreatic ductal adenocarcinoma and barriers to therapeutic efficacy. Front Oncol. 2021;11:2021.","DOI":"10.3389\/fonc.2021.688377"},{"key":"3033_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12010201","author":"P Chunarkar-Patil","year":"2024","unstructured":"Chunarkar-Patil P, Kaleem M, Mishra R, Ray S, Ahmad A, Verma D, et al. Anticancer drug discovery based on natural products: from computational approaches to clinical studies. Biomedicines. 2024. https:\/\/doi.org\/10.3390\/biomedicines12010201.","journal-title":"Biomedicines"},{"key":"3033_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.algal.2023.103262","volume":"75","author":"C Jim\u00e9nez-Gonz\u00e1lez","year":"2023","unstructured":"Jim\u00e9nez-Gonz\u00e1lez C, Agrasar AMT, Mallo F, R\u00faa ML, Fuci\u00f1os C. Red seaweed proteins: Valuable marine-origin compounds with encouraging applications. Algal Res. 2023;75:103262.","journal-title":"Algal Res"},{"key":"3033_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2024.106303","volume":"119","author":"Q-L Zhou","year":"2024","unstructured":"Zhou Q-L, Wang Z, Chen W-T, Liu X-F, Cheong K-L, Zou Y-X, et al. The structural characteristics, biological activities and mechanisms of bioactive brown seaweed polysaccharides: a review. J Funct Foods. 2024;119:106303.","journal-title":"J Funct Foods"},{"key":"3033_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodhyd.2023.108784","volume":"142","author":"EO Mensah","year":"2023","unstructured":"Mensah EO, Kanwugu ON, Panda PK, Adadi P. Marine fucoidans: Structural, extraction, biological activities and their applications in the food industry. Food Hydrocolloids. 2023;142:108784.","journal-title":"Food Hydrocolloids"},{"key":"3033_CR10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3390\/md21050307","volume":"21","author":"E Turrini","year":"2023","unstructured":"Turrini E, Maffei F, Fimognari C. Ten years of research on fucoidan and cancer: focus on its antiangiogenic and antimetastatic effects. Mar Drugs. 2023;21:307.","journal-title":"Mar Drugs"},{"key":"3033_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/md20120742","author":"H Zheng","year":"2022","unstructured":"Zheng H, Zhao Y, Guo L. A bioactive substance derived from brown seaweeds: phlorotannins. Mar Drugs. 2022. https:\/\/doi.org\/10.3390\/md20120742.","journal-title":"Mar Drugs"},{"key":"3033_CR12","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.3390\/antiox12091734","volume":"12","author":"L Sim\u00f3n","year":"2023","unstructured":"Sim\u00f3n L, Arazo-Rusindo M, Quest AFG, Mariotti-Celis MS. Phlorotannins: novel orally administrated bioactive compounds that induce mitochondrial dysfunction and oxidative stress in cancer. Antioxidants. 2023;12:1734.","journal-title":"Antioxidants"},{"key":"3033_CR13","doi-asserted-by":"publisher","first-page":"e1225","DOI":"10.1093\/nutrit\/nuae066","volume":"83","author":"L Goya","year":"2025","unstructured":"Goya L, Mateos R. Antioxidant and anti-inflammatory effects of marine phlorotannins and bromophenols supportive of their anticancer potential. Nutr Rev. 2025;83:e1225\u201342.","journal-title":"Nutr Rev"},{"key":"3033_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27041449","volume":"27","author":"D Matulja","year":"2022","unstructured":"Matulja D, Vranje\u0161evi\u0107 F, Kolympadi Markovic M, Paveli\u0107 SK, Markovi\u0107 D. Anticancer activities of marine-derived phenolic compounds and their derivatives. Molecules. 2022;27:1449.","journal-title":"Molecules"},{"key":"3033_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/md21020112","volume":"21","author":"YA Haggag","year":"2023","unstructured":"Haggag YA, Abd Elrahman AA, Ulber R, Zayed A. Fucoidan in pharmaceutical formulations: a comprehensive review for smart drug delivery systems. Mar Drugs. 2023;21:112.","journal-title":"Mar Drugs"},{"key":"3033_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.zool.2018.02.004","volume":"127","author":"C Bang","year":"2018","unstructured":"Bang C, Dagan T, Deines P, Dubilier N, Duschl WJ, Fraune S, et al. Metaorganisms in extreme environments: do microbes play a role in organismal adaptation? Zoology. 2018;127:1\u201319.","journal-title":"Zoology"},{"key":"3033_CR17","volume":"14","author":"N Ahmed","year":"2024","unstructured":"Ahmed N, Sheikh MA, Ubaid M, Chauhan P, Kumar K, Choudhary S. Comprehensive exploration of marine algae diversity, bioactive compounds, health benefits, regulatory issues, and food and drug applications. Measurement: Food. 2024;14:100163.","journal-title":"Measurement: Food"},{"key":"3033_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiec.2025.03.047","author":"D Nkurunziza","year":"2025","unstructured":"Nkurunziza D, Coad BR, Bulone V. A review on integrated biorefining of brown algae focusing on bioactive compounds and holistic biomass valorisation. J Ind Eng Chem. 2025. https:\/\/doi.org\/10.1016\/j.jiec.2025.03.047.","journal-title":"J Ind Eng Chem"},{"key":"3033_CR19","doi-asserted-by":"crossref","unstructured":"Carpena M, Garcia-Perez P, Garcia-Oliveira P, Chamorro F, Otero P, Louren\u00e7o-Lopes C, Cao H, Simal-Gandara J, Prieto MA. Biological properties and potential of compounds extracted from red seaweeds. Phytochem Rev Proc Phytochem Soc Europe. 2022; 1\u201332.","DOI":"10.1007\/s11101-022-09826-z"},{"key":"3033_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/md23040152","author":"E Cadar","year":"2025","unstructured":"Cadar E, Popescu A, Dragan AM, Pesterau AM, Pascale C, Anuta V, et al. Bioactive compounds of marine algae and their potential health and nutraceutical applications: a review. Mar Drugs. 2025. https:\/\/doi.org\/10.3390\/md23040152.","journal-title":"Mar Drugs"},{"key":"3033_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/md20040243","author":"NN Besednova","year":"2022","unstructured":"Besednova NN, Andryukov BG, Zaporozhets TS, Kuznetsova TA, Kryzhanovsky SP, Ermakova SP, et al. Molecular targets of brown algae phlorotannins for the therapy of inflammatory processes of various origins. Mar Drugs. 2022. https:\/\/doi.org\/10.3390\/md20040243.","journal-title":"Mar Drugs"},{"key":"3033_CR22","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s12032-025-02813-2","volume":"42","author":"M Narayanan","year":"2025","unstructured":"Narayanan M, Rajinikanth V. Effects of bioactive compounds from marine algae on cancer-related inflammation: a review. Medical oncology (Northwood, London, England). 2025;42:250.","journal-title":"Medical oncology (Northwood, London, England)"},{"key":"3033_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10311-022-01520-y","volume":"21","author":"M Farghali","year":"2023","unstructured":"Farghali M, Mohamed IMA, Osman AI, Rooney DW. Seaweed for climate mitigation, wastewater treatment, bioenergy, bioplastic, biochar, food, pharmaceuticals, and cosmetics: a review. Environ Chem Lett. 2023;21:97\u2013152.","journal-title":"Environ Chem Lett"},{"key":"3033_CR24","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.3390\/cancers16122240","volume":"16","author":"A Mukund","year":"2024","unstructured":"Mukund A, Afridi MA, Karolak A, Park MA, Permuth JB, Rasool G. Pancreatic ductal adenocarcinoma (PDAC): a review of recent advancements enabled by artificial intelligence. Cancers (Basel). 2024;16:2240.","journal-title":"Cancers (Basel)"},{"key":"3033_CR25","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3390\/md18110571","volume":"18","author":"A Zayed","year":"2020","unstructured":"Zayed A, El-Aasr M, Ibrahim A-RS, Ulber R. Fucoidan characterization: determination of purity and physicochemical and chemical properties. Mar Drugs. 2020;18:571.","journal-title":"Mar Drugs"},{"key":"3033_CR26","doi-asserted-by":"publisher","unstructured":"Li R, Luo P, Guo Y, He Y, Wang C. Clinical features, treatment, and prognosis of SGLT2 inhibitors induced acute pancreatitis. Expert Opin Drug Saf. 2024; 1\u20135. https:\/\/doi.org\/10.1080\/14740338.2024.2396387.","DOI":"10.1080\/14740338.2024.2396387"},{"key":"3033_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2025.e41964","volume":"11","author":"ANKV Sravani","year":"2025","unstructured":"Sravani ANKV, Thomas J. Targeting epithelial-mesenchymal transition signaling pathways with dietary phytocompounds and repurposed drug combinations for overcoming drug resistance in various cancers. Heliyon. 2025;11:e41964.","journal-title":"Heliyon"},{"key":"3033_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2025.123377","volume":"356","author":"HD Liu","year":"2025","unstructured":"Liu HD, Ma DY, Shi SR, Song SL, Li WL, Qi XH, et al. Preparation and bioactivities of low-molecular weight fucoidans and fuco-oligosaccharides: a review. Carbohydr Polym. 2025;356:123377.","journal-title":"Carbohydr Polym"},{"key":"3033_CR29","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1134\/S1063074022050169","volume":"48","author":"V Maheswari","year":"2022","unstructured":"Maheswari V, Babu PAS. Phlorotannin and its derivatives, a potential antiviral molecule from brown seaweeds, an overview. Russ J Mar Biol. 2022;48:309\u201324.","journal-title":"Russ J Mar Biol"},{"key":"3033_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpt.2025.02.006","author":"M Devaraji","year":"2025","unstructured":"Devaraji M, Thanikachalam PV. Phytoconstituents as emerging therapeutics for breast cancer: mechanistic insights and clinical implications. Cancer Pathog Ther. 2025. https:\/\/doi.org\/10.1016\/j.cpt.2025.02.006.","journal-title":"Cancer Pathog Ther"},{"key":"3033_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22648","volume":"35","author":"JW Xu","year":"2021","unstructured":"Xu JW, Yan Y, Wang L, Wu D, Ye NK, Chen SH, et al. Marine bioactive compound dieckol induces apoptosis and inhibits the growth of human pancreatic cancer cells PANC-1. J Biochem Mol Toxicol. 2021;35:e22648.","journal-title":"J Biochem Mol Toxicol"},{"key":"3033_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/md23020070","author":"S Frazzini","year":"2025","unstructured":"Frazzini S, Rossi L. Anticancer properties of macroalgae: a comprehensive review. Mar Drugs. 2025. https:\/\/doi.org\/10.3390\/md23020070.","journal-title":"Mar Drugs"},{"key":"3033_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.crbiot.2025.100300","volume":"10","author":"SS Abuzahrah","year":"2025","unstructured":"Abuzahrah SS, Elbehairi SEI, Bakhsh T, Atwa A, Juaid N, Mekky RH. Marine-derived secondary metabolites in oncology: a comprehensive review. Current Research in Biotechnology. 2025;10:100300.","journal-title":"Current Research in Biotechnology"},{"key":"3033_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/md20100638","author":"AI Usov","year":"2022","unstructured":"Usov AI, Bilan MI, Ustyuzhanina NE, Nifantiev NE. Fucoidans of brown algae: comparison of sulfated polysaccharides from Fucus vesiculosus and Ascophyllum nodosum. Mar Drugs. 2022. https:\/\/doi.org\/10.3390\/md20100638.","journal-title":"Mar Drugs"},{"key":"3033_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/md23010027","volume":"23","author":"M Chadwick","year":"2025","unstructured":"Chadwick M, Carvalho LG, Vanegas C, Dimartino S. A comparative review of alternative fucoidan extraction techniques from seaweed. Mar Drugs. 2025;23:27.","journal-title":"Mar Drugs"},{"key":"3033_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.matdes.2021.109465","volume":"202","author":"J Liu","year":"2021","unstructured":"Liu J, Li Z, Zhao D, Feng X, Wang C, Li D, et al. Immunogenic cell death-inducing chemotherapeutic nanoformulations potentiate combination chemoimmunotherapy. Mater Des. 2021;202:109465.","journal-title":"Mater Des"},{"key":"3033_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252111771","author":"S Jeong","year":"2024","unstructured":"Jeong S, Lee S, Lee G, Hyun J, Ryu B. Systematic characteristics of fucoidan: intriguing features for new pharmacological interventions. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms252111771.","journal-title":"Int J Mol Sci"},{"key":"3033_CR38","doi-asserted-by":"crossref","unstructured":"Duan X, Agar OT, Barrow CJ, Dunshea FR, Suleria HA. Improving potential strategies for biological activities of phlorotannins derived from seaweeds. Crit Rev Food Sci Nutr. 2025;65:833\u201355","DOI":"10.1080\/10408398.2023.2282669"},{"key":"3033_CR39","volume":"19","author":"C Bitwell","year":"2023","unstructured":"Bitwell C, Indra SS, Luke C, Kakoma MK. A review of modern and conventional extraction techniques and their applications for extracting phytochemicals from plants. Sci Afr. 2023;19:e01585.","journal-title":"Sci Afr"},{"key":"3033_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcoa.2023.100109","volume":"5","author":"F Eugelio","year":"2024","unstructured":"Eugelio F, Palmieri S, Fanti F, Buccioni F, Oliva E, Paparella A, et al. Development and validation of analytical method by micro-solid-phase extraction followed by ultra high performance liquid chromatography coupled to tandem mass spectrometry analysis for the quantification of Phomopsin A in lupin samples. J Chromatogr Open. 2024;5:100109.","journal-title":"J Chromatogr Open"},{"key":"3033_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2024.117627","volume":"173","author":"C Cannavacciuolo","year":"2024","unstructured":"Cannavacciuolo C, Pagliari S, Celano R, Campone L, Rastrelli L. Critical analysis of green extraction techniques used for botanicals: trends, priorities, and optimization strategies\u2014a review. TrAC Trends Anal Chem. 2024;173:117627.","journal-title":"TrAC Trends Anal Chem"},{"key":"3033_CR42","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3390\/md23060230","volume":"23","author":"ED Obluchinskaya","year":"2025","unstructured":"Obluchinskaya ED, Pozharitskaya ON, Lapina IM, Kulminskaya AA, Zhurishkina EV, Shikov AN. Comparative evaluation of dynamic maceration and ultrasonic assisted extraction of fucoidan from four Arctic brown algae on its antioxidant and anticancer properties. Mar Drugs. 2025;23:230.","journal-title":"Mar Drugs"},{"key":"3033_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.911861","volume":"9","author":"X Dai","year":"2022","unstructured":"Dai X, Shen L. Advances and trends in omics technology development. Front Med (Lausanne). 2022;9:911861.","journal-title":"Front Med (Lausanne)"},{"key":"3033_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/md19050265","author":"JO Jin","year":"2021","unstructured":"Jin JO, Chauhan PS, Arukha AP, Chavda V, Dubey A, Yadav D. The therapeutic potential of the anticancer activity of Fucoidan: current advances and hurdles. Mar Drugs. 2021. https:\/\/doi.org\/10.3390\/md19050265.","journal-title":"Mar Drugs"},{"key":"3033_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.145309","volume":"318","author":"R Gunarathne","year":"2025","unstructured":"Gunarathne R, Zhang C, Zhou J, Xin X, Lu J. Low molecular weight fucoidan: production methods and their therapeutic applications. Int J Biol Macromol. 2025;318:145309.","journal-title":"Int J Biol Macromol"},{"key":"3033_CR46","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10534-025-00672-y","volume":"38","author":"DB Le\u00f3n-Flores","year":"2025","unstructured":"Le\u00f3n-Flores DB, Sia\u00f1ez-Estada LI, Iglesias-Figueroa BF, Siqueiros-Cend\u00f3n TS, Espinoza-S\u00e1nchez EA, Varela-Ram\u00edrez A, et al. Anticancer potential of lactoferrin: effects, drug synergy and molecular interactions. Biometals. 2025;38:465\u201384.","journal-title":"Biometals"},{"key":"3033_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2024.122469","volume":"343","author":"O Plohl","year":"2024","unstructured":"Plohl O, Fras Zemlji\u010d L, Vihar B, Vesel A, Gyergyek S, Maver U, et al. Novel magnetic iron oxide-dextran sulphate nanocomposites as potential anticoagulants: investigating interactions with blood components and assessing cytotoxicity. Carbohydr Polym. 2024;343:122469.","journal-title":"Carbohydr Polym"},{"key":"3033_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.algal.2025.104105","volume":"90","author":"A Najibi","year":"2025","unstructured":"Najibi A, Gondo TF, Turner C. A review of analytical techniques for characterizing phlorotannins in brown seaweeds: current challenges and future prospects. Algal Res. 2025;90:104105.","journal-title":"Algal Res"},{"key":"3033_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2023.120965","volume":"314","author":"PAR Fernandes","year":"2023","unstructured":"Fernandes PAR, Coimbra MA. The antioxidant activity of polysaccharides: a structure-function relationship overview. Carbohyd Polym. 2023;314:120965.","journal-title":"Carbohyd Polym"},{"key":"3033_CR50","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/molecules28010002","volume":"28","author":"M Elbandy","year":"2022","unstructured":"Elbandy M. Anti-inflammatory effects of marine bioactive compounds and their potential as functional food ingredients in the prevention and treatment of neuroinflammatory disorders. Molecules. 2022;28:2.","journal-title":"Molecules"},{"key":"3033_CR51","doi-asserted-by":"publisher","unstructured":"Sanghvi G, Ballal DAS, Ariffin I, Singh A, Sabarivani A, Ray S, Joshi KK, Jain B. The biomedical frontier of fucoidan and laminarin: emerging insights. J Biomater Sci Polym Edition. 2025;1\u201366.https:\/\/doi.org\/10.1080\/09205063.2025.2523506.","DOI":"10.1080\/09205063.2025.2523506"},{"key":"3033_CR52","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/mas.21575","volume":"39","author":"RM Gathungu","year":"2020","unstructured":"Gathungu RM, Kautz R, Kristal BS, Bird SS, Vouros P. The integration of LC-MS and NMR for the analysis of low molecular weight trace analytes in complex matrices. Mass Spectrom Rev. 2020;39:35\u201354.","journal-title":"Mass Spectrom Rev"},{"key":"3033_CR53","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/md18010045","volume":"18","author":"H Bae","year":"2020","unstructured":"Bae H, Lee J-Y, Yang C, Song G, Lim W. Fucoidan derived from fucus vesiculosus inhibits the development of human ovarian cancer via the disturbance of calcium homeostasis, endoplasmic reticulum stress, and angiogenesis. Mar Drugs. 2020;18:45.","journal-title":"Mar Drugs"},{"key":"3033_CR54","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1039\/D3FO04807A","volume":"15","author":"H Li","year":"2024","unstructured":"Li H, Dong T, Tao M, Zhao H, Lan T, Yan S, et al. Fucoidan enhances the anti-tumor effect of anti-PD-1 immunotherapy by regulating gut microbiota. Food Funct. 2024;15:3463\u201378.","journal-title":"Food Funct"},{"key":"3033_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.134517","volume":"277","author":"Z Zheng","year":"2024","unstructured":"Zheng Z, Li M, Yang J, Zhou X, Chen Y, Silli EK, et al. Growth inhibition of pancreatic cancer by targeted delivery of gemcitabine via fucoidan-coated pH-sensitive liposomes. Int J Biol Macromol. 2024;277:134517.","journal-title":"Int J Biol Macromol"},{"key":"3033_CR56","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3390\/md20120754","volume":"20","author":"MD Catarino","year":"2022","unstructured":"Catarino MD, Pires SMG, Silva S, Costa F, Braga SS, Pinto DCGA, et al. Overview of phlorotannins\u2019 constituents in Fucales. Mar Drugs. 2022;20:754.","journal-title":"Mar Drugs"},{"key":"3033_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/md20060387","author":"P Monteiro","year":"2022","unstructured":"Monteiro P, Lomartire S, Cotas J, Marques JC, Pereira L, Gon\u00e7alves AMM. Call the Eckols: present and future potential cancer therapies. Mar Drugs. 2022. https:\/\/doi.org\/10.3390\/md20060387.","journal-title":"Mar Drugs"},{"key":"3033_CR58","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1186\/s12885-018-4845-0","volume":"18","author":"KM Mrozik","year":"2018","unstructured":"Mrozik KM, Blaschuk OW, Cheong CM, Zannettino ACW, Vandyke K. N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer. BMC Cancer. 2018;18:939.","journal-title":"BMC Cancer"},{"key":"3033_CR59","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s43094-023-00492-2","volume":"9","author":"R Sharma","year":"2023","unstructured":"Sharma R, Mondal AS, Trivedi N. Anticancer potential of algae-derived metabolites: recent updates and breakthroughs. Future J Pharm Sci. 2023;9:44.","journal-title":"Future J Pharm Sci"},{"key":"3033_CR60","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","volume":"23","author":"X Lin","year":"2024","unstructured":"Lin X, Kang K, Chen P, Zeng Z, Li G, Xiong W, et al. Regulatory mechanisms of PD-1\/PD-L1 in cancers. Mol Cancer. 2024;23:108.","journal-title":"Mol Cancer"},{"key":"3033_CR61","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1007\/s10811-022-02749-4","volume":"34","author":"LRG Kumar","year":"2022","unstructured":"Kumar LRG, Paul PT, Anas KK, Tejpal CS, Chatterjee NS, Anupama TK, et al. Phlorotannins-bioactivity and extraction perspectives. J Appl Phycol. 2022;34:2173\u201385.","journal-title":"J Appl Phycol"},{"key":"3033_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12091734","author":"L Sim\u00f3n","year":"2023","unstructured":"Sim\u00f3n L, Arazo-Rusindo M, Quest AFG, Mariotti-Celis MS. Phlorotannins: novel orally administrated bioactive compounds that induce mitochondrial dysfunction and oxidative stress in cancer. Antioxidants (Basel, Switzerland). 2023. https:\/\/doi.org\/10.3390\/antiox12091734.","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"3033_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216859","volume":"591","author":"Q Qin","year":"2024","unstructured":"Qin Q, Yu R, Eriksson JE, Tsai H-I, Zhu H. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: challenges and opportunities. Cancer Lett. 2024;591:216859.","journal-title":"Cancer Lett"},{"key":"3033_CR64","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.2147\/CMAR.S243495","volume":"12","author":"Y Duan","year":"2020","unstructured":"Duan Y, Li J, Jing X, Ding X, Yu Y, Zhao Q. Fucoidan induces apoptosis and inhibits proliferation of hepatocellular carcinoma via the p38 MAPK\/ERK and PI3K\/Akt signal pathways. Cancer Manag Res. 2020;12:1713\u201323.","journal-title":"Cancer Manag Res"},{"key":"3033_CR65","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3390\/md22030114","volume":"22","author":"DS Dalisay","year":"2024","unstructured":"Dalisay DS, Tenebro CP, Sabido EM, Suarez AFL, Paderog MJV, Reyes-Salarda R, et al. Marine-derived anticancer agents targeting apoptotic pathways: exploring the depths for novel cancer therapies. Mar Drugs. 2024;22:114.","journal-title":"Mar Drugs"},{"key":"3033_CR66","doi-asserted-by":"crossref","unstructured":"Liu S, Sun WC, Zhang YL, Lin QY, Liao JW, Song GR, Ma XL, Li HH, Zhang B. SOCS3 negatively regulates cardiac hypertrophy via targeting GRP78-mediated ER stress during pressure overload. Front Cell Dev Biol. 2021;9:2021.","DOI":"10.3389\/fcell.2021.629932"},{"key":"3033_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/md22010029","author":"A Zayed","year":"2023","unstructured":"Zayed A, Al-Saedi DA, Mensah EO, Kanwugu ON, Adadi P, Ulber R. Fucoidan\u2019s molecular targets: a comprehensive review of its unique and multiple targets accounting for promising bioactivities supported by in silico studies. Mar Drugs. 2023. https:\/\/doi.org\/10.3390\/md22010029.","journal-title":"Mar Drugs"},{"key":"3033_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/biom14091178","author":"R Szydlak","year":"2024","unstructured":"Szydlak R. Synergistic inhibition of pancreatic cancer cell growth and migration by gemcitabine and withaferin A. Biomolecules. 2024. https:\/\/doi.org\/10.3390\/biom14091178.","journal-title":"Biomolecules"},{"key":"3033_CR69","doi-asserted-by":"publisher","DOI":"10.1200\/OA-24-00050","volume":"1","author":"JM Finan","year":"2024","unstructured":"Finan JM, Guo Y, Goodyear SM, Brody JR. Challenges and opportunities in targeting the complex Pancreatic tumor microenvironment. JCO Oncol Adv. 2024;1:e2400050.","journal-title":"JCO Oncol Adv"},{"key":"3033_CR70","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1177\/1534735418775828","volume":"17","author":"C Zhang","year":"2018","unstructured":"Zhang C, Wang N, Tan HY, Guo W, Li S, Feng Y. Targeting VEGF\/VEGFRs pathway in the antiangiogenic treatment of human cancers by traditional Chinese medicine. Integr Cancer Ther. 2018;17:582\u2013601.","journal-title":"Integr Cancer Ther"},{"key":"3033_CR71","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/jso.23240","volume":"107","author":"T Liu","year":"2013","unstructured":"Liu T, Zhang X, Shang M, Zhang Y, Xia B, Niu M, et al. Dysregulated expression of Slug, vimentin, and E-cadherin correlates with poor clinical outcome in patients with basal-like breast cancer. J Surg Oncol. 2013;107:188\u201394.","journal-title":"J Surg Oncol"},{"key":"3033_CR72","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cpt.2024.07.004","volume":"3","author":"R Liu","year":"2025","unstructured":"Liu R, Li J, Liu L, Wang W, Jia J. Tumor-associated macrophages (TAMs): constructing an immunosuppressive microenvironment bridge for pancreatic ductal adenocarcinoma (PDAC). Cancer Pathogen Therapy. 2025;3:183\u201396.","journal-title":"Cancer Pathogen Therapy"},{"key":"3033_CR73","first-page":"81","volume":"12","author":"T Nagamine","year":"2020","unstructured":"Nagamine T, Kadena K, Tomori M, Nakajima K, Iha M. Activation of NK cells in male cancer survivors by fucoidan extracted from Cladosiphon okamuranus. Mol Clin Oncol. 2020;12:81\u20138.","journal-title":"Mol Clin Oncol"},{"key":"3033_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.algal.2025.103907","volume":"86","author":"M Maghimaa","year":"2025","unstructured":"Maghimaa M, Sagadevan S, Fatimah I, Lett JA, Garg S. Exploring algal diversity for enhanced nutrition: implications for human health and sustainability. Algal Res. 2025;86:103907.","journal-title":"Algal Res"},{"key":"3033_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/md22090424","author":"G Yang","year":"2024","unstructured":"Yang G, Lin M, Kaliaperumal K, Lu Y, Qi X, Jiang X, et al. Recent advances in anti-inflammatory compounds from marine microorganisms. Mar Drugs. 2024. https:\/\/doi.org\/10.3390\/md22090424.","journal-title":"Mar Drugs"},{"key":"3033_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2024.118836","volume":"252","author":"H-A Ha","year":"2024","unstructured":"Ha H-A, Aloufi AS, Parveen B. Essential bioactive competence of laminarin (\u03b2-glucan)\/ laminaran extracted from Padina tetrastromatica and Sargassum cinereum biomass. Environ Res. 2024;252:118836.","journal-title":"Environ Res"},{"key":"3033_CR77","doi-asserted-by":"crossref","unstructured":"Thiraviyam P, Aafreen, Kannan K, Ganapathy D, Sivaperumal P. Evaluation of antioxidant and antibacterial activities of seagrass Cymodocea serrulate. Discov Plants. 2025;2:68.","DOI":"10.1007\/s44372-025-00147-x"},{"key":"3033_CR78","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3390\/cancers15030715","volume":"15","author":"PP Bhuyan","year":"2023","unstructured":"Bhuyan PP, Nayak R, Patra S, Abdulabbas HS, Jena M, Pradhan B. Seaweed-derived sulfated polysaccharides, the new age chemopreventives: a comprehensive review. Cancers. 2023;15:715.","journal-title":"Cancers"},{"key":"3033_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.phyplu.2023.100418","volume":"3","author":"A Deep","year":"2023","unstructured":"Deep A, Kumar D, Bansal N, Narasimhan B, Marwaha RK, Sharma PC. Understanding mechanistic aspects and therapeutic potential of natural substances as anticancer agents. Phytomedicine Plus. 2023;3:100418.","journal-title":"Phytomedicine Plus"},{"key":"3033_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114505","volume":"161","author":"J Gong","year":"2023","unstructured":"Gong J, Shi T, Liu J, Pei Z, Liu J, Ren X, et al. Dual-drug codelivery nanosystems: an emerging approach for overcoming cancer multidrug resistance. Biomed Pharmacother. 2023;161:114505.","journal-title":"Biomed Pharmacother"},{"key":"3033_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115015","volume":"164","author":"M Nigam","year":"2023","unstructured":"Nigam M, Mishra AP, Deb VK, Dimri DB, Tiwari V, Bungau SG, et al. Evaluation of the association of chronic inflammation and cancer: insights and implications. Biomed Pharmacother. 2023;164:115015.","journal-title":"Biomed Pharmacother"},{"key":"3033_CR82","doi-asserted-by":"publisher","unstructured":"Selvaraj H. Harnessing the ocean\u2019s pharmacy: marine bioactive compounds as next-generation therapeutics. Nat Prod Res. 2024; 1\u20132. https:\/\/doi.org\/10.1080\/14786419.2024.2373965.","DOI":"10.1080\/14786419.2024.2373965"},{"key":"3033_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.bea.2024.100116","volume":"7","author":"S Karuppannan","year":"2024","unstructured":"Karuppannan S, Sivakumar M, Govindasamy B, Chinnaraj S, Maluventhan V, Arumugam M. Reliable quality of R-phycoerythrin derived from Portieria hornemannii for effective antioxidant, antibacterial, and anticancer activity. Biomed Eng Adv. 2024;7:100116.","journal-title":"Biomed Eng Adv"},{"key":"3033_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23147824","author":"R Fujiwara-Tani","year":"2022","unstructured":"Fujiwara-Tani R, Sasaki T, Takagi T, Mori S, Kishi S, Nishiguchi Y, et al. Gemcitabine resistance in pancreatic ductal carcinoma cell lines stems from reprogramming of energy metabolism. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23147824.","journal-title":"Int J Mol Sci"},{"key":"3033_CR85","first-page":"7","volume":"13","author":"H Abbasi","year":"2023","unstructured":"Abbasi H, Kouchak M, Mirveis Z, Hajipour F, Khodarahmi M, Rahbar N, et al. What we need to know about liposomes as drug nanocarriers: an updated review. Adv Pharm Bull. 2023;13:7\u201323.","journal-title":"Adv Pharm Bull"},{"key":"3033_CR86","doi-asserted-by":"publisher","unstructured":"Deivayanai VC, Thamarai P, Karishma S, Saravanan A, Yaashikaa PR, Vickram AS, Hemavathy RV, Kumar RR, Rishikesavan S, Shruthi S. A comprehensive review on advances in nanoparticle-mediated cancer therapeutics: current research and future perspectives. Cancer Pathogen Therapy. 2025; 9; 3(4): 293. https:\/\/doi.org\/10.1016\/j.cpt.2024.11.002.","DOI":"10.1016\/j.cpt.2024.11.002"},{"key":"3033_CR87","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12866-025-03763-5","volume":"25","author":"SJ Nisha","year":"2025","unstructured":"Nisha SJ, Uma G, Sathishkumar R, Prakash VSG, Isaac R, Citarasu T. Optimization and characterization of bioactive secondary metabolites from Streptomyces sp CMSTAAHL-4 isolated from mangrove sediment. BMC Microbiol. 2025;25:57.","journal-title":"BMC Microbiol"},{"key":"3033_CR88","doi-asserted-by":"publisher","first-page":"103961","DOI":"10.1016\/j.critrevonc.2023.103961","volume":"185","author":"S Bhattacharya","year":"2023","unstructured":"Bhattacharya S, Prajapati BG, Singh S. A critical review on the dissemination of PH and stimuli-responsive polymeric nanoparticular systems to improve drug delivery in cancer therapy. Crit Rev Oncol Hematol. 2023;185:103961.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3033_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/md19110625","author":"T Tong","year":"2021","unstructured":"Tong T, Liu X, Yu C. Extraction and nano-sized delivery systems for phlorotannins to improve its bioavailability and bioactivity. Mar Drugs. 2021. https:\/\/doi.org\/10.3390\/md19110625.","journal-title":"Mar Drugs"},{"key":"3033_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252413662","volume":"25","author":"A Muscella","year":"2024","unstructured":"Muscella A, Cossa LG, Stef\u00e0no E, Rovito G, Benedetti M, Fanizzi FP, et al. Different cytotoxic effects of Cisplatin on pancreatic ductal adenocarcinoma cell lines. Int J Mol Sci. 2024;25:13662.","journal-title":"Int J Mol Sci"},{"key":"3033_CR91","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s10456-023-09876-7","volume":"26","author":"AC Dudley","year":"2023","unstructured":"Dudley AC, Griffioen AW. Pathological angiogenesis: mechanisms and therapeutic strategies. Angiogenesis. 2023;26:313\u201347.","journal-title":"Angiogenesis"},{"key":"3033_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/biom10020248","volume":"10","author":"E Wang","year":"2020","unstructured":"Wang E, Sorolla MA, Krishnan PDG, Sorolla A. From seabed to bedside: a review on promising marine anticancer compounds. Biomolecules. 2020;10:248.","journal-title":"Biomolecules"},{"key":"3033_CR93","doi-asserted-by":"publisher","first-page":"571","DOI":"10.4251\/wjgo.v15.i4.571","volume":"15","author":"YT Fang","year":"2023","unstructured":"Fang YT, Yang WW, Niu YR, Sun YK. Recent advances in targeted therapy for pancreatic adenocarcinoma. World J Gastrointest Oncol. 2023;15:571\u201395.","journal-title":"World J Gastrointest Oncol"},{"key":"3033_CR94","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1549419","volume":"16","author":"Y Bin","year":"2025","unstructured":"Bin Y, Peng R, Lee Y, Lee Z, Liu Y. Efficacy of xuebijing injection on pulmonary ventilation improvement in acute pancreatitis: a systematic review and meta-analysis. Front Pharmacol. 2025;16:2025.","journal-title":"Front Pharmacol"},{"key":"3033_CR95","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.semcancer.2024.09.002","volume":"106\u2013107","author":"G Lencioni","year":"2024","unstructured":"Lencioni G, Gregori A, Toledo B, Rebelo R, Immordino B, Amrutkar M, et al. Unravelling the complexities of resistance mechanism in pancreatic cancer: Insights from in vitro and ex-vivo model systems. Semin Cancer Biol. 2024;106\u2013107:217\u201333.","journal-title":"Semin Cancer Biol"},{"key":"3033_CR96","volume":"17","author":"H Jang","year":"2024","unstructured":"Jang H, Lee J, Park Y-K, Lee J-Y. Exploring the health benefits and concerns of brown seaweed consumption: a comprehensive review of bioactive compounds in brown seaweed and its potential therapeutic effects. J Agric Food Res. 2024;17:101215.","journal-title":"J Agric Food Res"},{"key":"3033_CR97","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","volume":"12","author":"D Sun","year":"2022","unstructured":"Sun D, Gao W, Hu H, Zhou S. Why 90% of clinical drug development fails and how to improve it? Acta pharmaceutica Sinica B. 2022;12:3049\u201362.","journal-title":"Acta pharmaceutica Sinica B"},{"key":"3033_CR98","doi-asserted-by":"publisher","first-page":"6032","DOI":"10.3390\/molecules27186032","volume":"27","author":"J-O Jin","year":"2022","unstructured":"Jin J-O, Yadav D, Madhwani K, Puranik N, Chavda V, Song M. Seaweeds in the oncology arena: anti-cancer potential of Fucoidan as a drug\u2014a review. Molecules. 2022;27:6032.","journal-title":"Molecules"},{"key":"3033_CR99","doi-asserted-by":"publisher","first-page":"104557","DOI":"10.1016\/j.yrtph.2019.104557","volume":"111","author":"AW Hayes","year":"2020","unstructured":"Hayes AW, Pressman P, Hardisty JF, Harris SB, Weber K. Oral repeated-dose toxicity studies of BIA 10\u20132474 in CD-1 mice. Regul Toxicol Pharmacol. 2020;111:104557.","journal-title":"Regul Toxicol Pharmacol"},{"key":"3033_CR100","doi-asserted-by":"publisher","DOI":"10.3390\/toxins14050312","author":"D Harwanto","year":"2022","unstructured":"Harwanto D, Negara B, Tirtawijaya G, Meinita MDN, Choi JS. Evaluation of toxicity of crude phlorotannins and phloroglucinol using different model organisms. Toxins (Basel). 2022. https:\/\/doi.org\/10.3390\/toxins14050312.","journal-title":"Toxins (Basel)"},{"key":"3033_CR101","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1009295","volume":"17","author":"L Zhang","year":"2021","unstructured":"Zhang L, Wang J, von Kleist M. Numerical approaches for the rapid analysis of prophylactic efficacy against HIV with arbitrary drug-dosing schemes. PLoS Comput Biol. 2021;17:e1009295.","journal-title":"PLoS Comput Biol"},{"key":"3033_CR102","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12943-023-01865-0","volume":"22","author":"M Chehelgerdi","year":"2023","unstructured":"Chehelgerdi M, Chehelgerdi M, Allela OQB, Pecho RDC, Jayasankar N, Rao DP, et al. Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. Mol Cancer. 2023;22:169.","journal-title":"Mol Cancer"},{"key":"3033_CR103","doi-asserted-by":"publisher","first-page":"e4788","DOI":"10.1002\/jms.4788","volume":"56","author":"VP Gaspar","year":"2021","unstructured":"Gaspar VP, Ibrahim S, Zahedi RP, Borchers CH. Utility, promise, and limitations of liquid chromatography-mass spectrometry-based therapeutic drug monitoring in precision medicine. J Mass Spectrometry: JMS. 2021;56:e4788.","journal-title":"J Mass Spectrometry: JMS"},{"key":"3033_CR104","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/stresses5010022","volume":"5","author":"IN Monroy-Garc\u00eda","year":"2025","unstructured":"Monroy-Garc\u00eda IN, Torres-Romero S, Castro-Ochoa LD, Mendoza-Acosta A, Viveros-Valdez E, Ayala-Zavala F. Bioactive compounds from marine macroalgae: a natural defense against oxidative stress-related diseases. Stresses. 2025;5:22.","journal-title":"Stresses"},{"key":"3033_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2020.104647","volume":"114","author":"S Thakkar","year":"2020","unstructured":"Thakkar S, Anklam E, Xu A, Ulberth F, Li J, Li B, et al. Regulatory landscape of dietary supplements and herbal medicines from a global perspective. Regul Toxicol Pharmacol. 2020;114:104647.","journal-title":"Regul Toxicol Pharmacol"},{"key":"3033_CR106","doi-asserted-by":"publisher","unstructured":"Zayed A, El-Aasr M, Ibrahim AS, Ulber R. Fucoidan characterization: determination of purity and physicochemical and chemical properties. Mar Drugs. 2020;18 (11) 571. https:\/\/doi.org\/10.3390\/md18110571.","DOI":"10.3390\/md18110571"},{"key":"3033_CR107","volume":"10","author":"P Vosoughi","year":"2025","unstructured":"Vosoughi P, Naghib SM, Jafari T, Kangarshahi BM. Chitosan-encapsulated lipid-based nanovesicles for therapeutic applications and tissue engineering: a review. Carbohydr Polym Technol Appl. 2025;10:100805.","journal-title":"Carbohydr Polym Technol Appl"},{"key":"3033_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2024.101443","volume":"7","author":"A Augustyniak","year":"2024","unstructured":"Augustyniak A, Przyborska J, McMahon H. Differential effects of Fucus vesiculosus fucoidan on fibroblast and macrophage cell lines inflammatory activation. Results Chem. 2024;7:101443.","journal-title":"Results Chem"},{"key":"3033_CR109","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14091781","author":"BS Negreanu-Pirjol","year":"2022","unstructured":"Negreanu-Pirjol BS, Negreanu-Pirjol T, Popoviciu DR, Anton RE, Prelipcean AM. Marine bioactive compounds derived from macroalgae as new potential players in drug delivery systems: a review. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14091781.","journal-title":"Pharmaceutics"},{"key":"3033_CR110","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.xphs.2020.09.048","volume":"110","author":"MN Ruesch","year":"2021","unstructured":"Ruesch MN, Benetti L, Berkay E, Cirelli DJ, Frantz N, Gastens MH, et al. Strategies for setting patient-centric commercial specifications for biotherapeutic products. J Pharm Sci. 2021;110:771\u201384.","journal-title":"J Pharm Sci"},{"key":"3033_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.aichem.2024.100072","volume":"2","author":"O Kapustina","year":"2024","unstructured":"Kapustina O, Burmakina P, Gubina N, Serov N, Vinogradov V. User-friendly and industry-integrated AI for medicinal chemists and pharmaceuticals. Artif Intell Chem. 2024;2:100072.","journal-title":"Artif Intell Chem"},{"key":"3033_CR112","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.semcancer.2025.05.004","volume":"113","author":"G Peduzzi","year":"2025","unstructured":"Peduzzi G, Archibugi L, Farinella R, de Leon Pisani RP, Vodickova L, Vodicka P, et al. The exposome and pancreatic cancer, lifestyle and environmental risk factors for PDAC. Semin Cancer Biol. 2025;113:100\u201329.","journal-title":"Semin Cancer Biol"},{"key":"3033_CR113","doi-asserted-by":"publisher","DOI":"10.3390\/proteomes12030025","author":"R Vitorino","year":"2024","unstructured":"Vitorino R. Transforming clinical research: the power of high-throughput omics integration. Proteomes. 2024. https:\/\/doi.org\/10.3390\/proteomes12030025.","journal-title":"Proteomes"},{"key":"3033_CR114","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27186032","author":"JO Jin","year":"2022","unstructured":"Jin JO, Yadav D, Madhwani K, Puranik N, Chavda V, Song M. Seaweeds in the oncology arena: anti-cancer potential of Fucoidan as a drug-a review. Molecules. 2022. https:\/\/doi.org\/10.3390\/molecules27186032.","journal-title":"Molecules"},{"key":"3033_CR115","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252313121","volume":"25","author":"K Wu","year":"2024","unstructured":"Wu K, Kwon SH, Zhou X, Fuller C, Wang X, Vadgama J, et al. Overcoming challenges in small-molecule drug bioavailability: a review of key factors and approaches. Int J Mol Sci. 2024;25:13121.","journal-title":"Int J Mol Sci"},{"key":"3033_CR116","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jconrel.2024.07.023","volume":"373","author":"E Minaei","year":"2024","unstructured":"Minaei E, Ranson M, Aghmesheh M, Sluyter R, Vine KL. Enhancing pancreatic cancer immunotherapy: leveraging localized delivery strategies through the use of implantable devices and scaffolds. J Control Release. 2024;373:145\u201360.","journal-title":"J Control Release"},{"key":"3033_CR117","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/jnci\/djac232","volume":"115","author":"EL Korn","year":"2023","unstructured":"Korn EL, Moscow JA, Freidlin B. Dose optimization during drug development: whether and when to optimize. J Natl Cancer Inst. 2023;115:492\u20137.","journal-title":"J Natl Cancer Inst"},{"key":"3033_CR118","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-024-00433-x","volume":"4","author":"D Mahalingam","year":"2024","unstructured":"Mahalingam D, Harb W, Patnaik A, Bullock A, Watnick RS, Vincent MY, et al. First-in-human phase I dose escalation trial of the first-in-class tumor microenvironment modulator VT1021 in advanced solid tumors. Commun Med. 2024;4:10.","journal-title":"Commun Med"},{"key":"3033_CR119","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12935-020-01233-8","volume":"20","author":"Y Lin","year":"2020","unstructured":"Lin Y, Qi X, Liu H, Xue K, Xu S, Tian Z. The anti-cancer effects of fucoidan: a review of both in vivo and in vitro investigations. Cancer Cell Int. 2020;20:154.","journal-title":"Cancer Cell Int"},{"key":"3033_CR120","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.chmed.2024.11.010","volume":"17","author":"M Sajana","year":"2025","unstructured":"Sajana M, Gopenath TS, Kanthesh BM. A comprehensive review of phytochemical approaches in treatment of acute myeloid leukemia: associated pathways and molecular mechanisms. Chin Herbal Med. 2025;17:41\u201355.","journal-title":"Chin Herbal Med"},{"key":"3033_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2022.103460","volume":"28","author":"A Palermo","year":"2023","unstructured":"Palermo A. Metabolomics- and systems-biology-guided discovery of metabolite lead compounds and druggable targets. Drug Discov Today. 2023;28:103460.","journal-title":"Drug Discov Today"},{"key":"3033_CR122","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911821","author":"MV Kiselevskiy","year":"2022","unstructured":"Kiselevskiy MV, Anisimova NY, Ustyuzhanina NE, Vinnitskiy DZ, Tokatly AI, Reshetnikova VV, et al. Perspectives for the use of fucoidans in clinical oncology. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms231911821.","journal-title":"Int J Mol Sci"},{"key":"3033_CR123","doi-asserted-by":"publisher","unstructured":"Mildau K, Ehlers H, Meisenburg M, Del Pup E, Koetsier RA, Torres Ortega LR, de Jonge NF, Singh KS, Ferreira D, Othibeng K, Tugizimana F, Huber F, van der Hooft JJJ. Effective data visualization strategies in untargeted metabolomics. Nat Prod Rep. 2025;42(6):982-1019. https:\/\/doi.org\/10.1039\/D4NP00039K.","DOI":"10.1039\/D4NP00039K"},{"key":"3033_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102226","volume":"51","author":"S Taurin","year":"2025","unstructured":"Taurin S, Alzahrani R, Aloraibi S, Ashi L, Alharmi R, Hassani N. Patient-derived tumor organoids: a preclinical platform for personalized cancer therapy. Transl Oncol. 2025;51:102226.","journal-title":"Transl Oncol"},{"key":"3033_CR125","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.imj.2022.08.004","volume":"1","author":"B Madhogaria","year":"2022","unstructured":"Madhogaria B, Bhowmik P, Kundu A. Correlation between human gut microbiome and diseases. Infectious Medicine. 2022;1:180\u201391.","journal-title":"Infectious Medicine"},{"key":"3033_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2023.101143","volume":"11","author":"X Wang","year":"2024","unstructured":"Wang X, Yang J, Ren B, Yang G, Liu X, Xiao R, et al. Comprehensive multi-omics profiling identifies novel molecular subtypes of pancreatic ductal adenocarcinoma. Genes Dis. 2024;11:101143.","journal-title":"Genes Dis"},{"key":"3033_CR127","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.medj.2024.08.010","volume":"5","author":"L Tong","year":"2024","unstructured":"Tong L, Cui W, Zhang B, Fonseca P, Zhao Q, Zhang P, et al. Patient-derived organoids in precision cancer medicine. Med. 2024;5:1351\u201377.","journal-title":"Med"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03033-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-03033-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03033-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T11:02:50Z","timestamp":1762426970000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-03033-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":127,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["3033"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-03033-4","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,15]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"For language improvement QuillBolt software was used.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Artificial intelligence (AI)"}}],"article-number":"473"}}